Rallybio Corporation

NASDAQ: RLYB · Real-Time Price · USD
0.57
0.02 (4.40%)
At close: Aug 15, 2025, 3:10 PM

Rallybio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-57.77M -74.56M -66.65M -47.01M
Depreciation & Amortization
131K 150K 167K 109K
Stock-Based Compensation
7.99M 10.92M 9.5M 3.65M
Other Working Capital
440K 4.38M -1.42M -2.8M
Other Non-Cash Items
627K -1.05M 640K 1.5M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-258K 4.28M -936K -3.78M
Operating Cash Flow
-49.28M -60.27M -57.28M -45.53M
Capital Expenditures
n/a -12K -54K -333K
Cash Acquisitions
n/a -2.25M -300K -2M
Purchase of Investments
-48.93M -110.66M -201.32M -2M
Sales Maturities Of Investments
84.42M 138.33M 89.5M 2M
Other Investing Acitivies
-2M 2.25M -112.12K -2K
Investing Cash Flow
33.49M 27.66M -112.17M -2.33M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
62K 282K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-206K 143K -455K -3.23M
Financial Cash Flow
5.2M 143K 51.08M 82.97M
Net Cash Flow
-10.59M -32.46M -118.38M 35.1M
Free Cash Flow
-49.28M -60.28M -57.34M -45.87M